We are live on ! Find out more
RPI

Railway Pension Investments Portfolio holdings

AUM $7.95B
1-Year Est. Return 27.91%
This Fund
S&P 500
This Quarter Est. Return
+10.04%
1 Year Est. Return
+27.91%
3 Year Est. Return
+90.81%
5 Year Est. Return
+114.66%
10 Year Est. Return
AUM
$9.95B
AUM Growth
+$741M
Cap. Flow
-$19.5M
Cap. Flow %
-0.2%
Top 10 Hldgs %
21.61%
Holding
246
New
12
Increased
90
Reduced
21
Closed
23

Top Buys

Rank Stock Value
1
CMCSA icon
Comcast
CMCSA
+$47.2M
2
PFE icon
Pfizer
PFE
+$43.7M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$38.6M
4
APA icon
APA Corp
APA
+$36.8M
5
WMT icon
Walmart Inc
WMT
+$30.6M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$92.9M
2
AMGN icon
Amgen
AMGN
+$92.4M
3
TMO icon
Thermo Fisher Scientific
TMO
+$71.6M
4
IBM icon
IBM
IBM
+$47.2M
5
TGT icon
Target
TGT
+$45.1M

Sector Composition

Rank Sector Weight
1 Healthcare 33.1%
2 Technology 21.61%
3 Consumer Staples 13.71%
4 Consumer Discretionary 9.61%
5 Industrials 6.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
V icon
1
Visa
V
$717B
$292M 2.93%
1,405,439
TXN icon
2
Texas Instruments
TXN
$239B
$243M 2.44%
1,470,755
+7,600
+0.5% +$1.27M
UNH icon
3
UnitedHealth
UNH
$360B
$226M 2.27%
426,020
+5,800
+1% +$3.07M
NEE icon
4
NextEra Energy
NEE
$176B
$218M 2.19%
2,611,632
GILD icon
5
Gilead Sciences
GILD
$184B
$209M 2.1%
2,438,765
+266,100
+12% +$21.1M
ACN icon
6
Accenture
ACN
$111B
$199M 2%
745,421
+4,400
+0.6% +$1.22M
TMO icon
7
Thermo Fisher Scientific
TMO
$234B
$199M 2%
360,900
-135,076
-27% -$71.6M
DHR icon
8
Danaher
DHR
$151B
$195M 1.96%
828,064
PG icon
9
Procter & Gamble
PG
$337B
$189M 1.9%
1,248,963
+14,200
+1% +$1.99M
ELV icon
10
Elevance Health
ELV
$87.3B
$181M 1.82%
353,217
+800
+0.2% +$406K
MRK icon
11
Merck
MRK
$378B
$180M 1.8%
1,618,450
+84,700
+6% +$8.66M
PEP icon
12
PepsiCo
PEP
$194B
$179M 1.8%
992,584
+51,100
+5% +$9.11M
JNJ icon
13
Johnson & Johnson
JNJ
$651B
$177M 1.78%
1,000,536
-134,700
-12% -$23.3M
CVS icon
14
CVS Health
CVS
$121B
$159M 1.6%
1,708,846
+59,800
+4% +$5.77M
HD icon
15
Home Depot
HD
$334B
$157M 1.58%
498,389
+8,600
+2% +$2.62M
ABBV icon
16
AbbVie
ABBV
$465B
$156M 1.57%
966,431
-606,000
-39% -$92.9M
TSM icon
17
TSMC
TSM
$2.17T
$153M 1.53%
2,047,683
LLY icon
18
Eli Lilly
LLY
$1.06T
$152M 1.53%
416,432
+2,300
+0.6% +$815K
NOW icon
19
ServiceNow
NOW
$130B
$142M 1.42%
1,823,000
EQIX icon
20
Equinix
EQIX
$107B
$139M 1.4%
212,869
SPGI icon
21
S&P Global
SPGI
$129B
$139M 1.39%
413,800
MSFT icon
22
Microsoft
MSFT
$3.69T
$139M 1.39%
577,600
PFE icon
23
Pfizer
PFE
$161B
$138M 1.39%
2,700,492
+911,600
+51% +$43.7M
BMY icon
24
Bristol-Myers Squibb
BMY
$138B
$137M 1.38%
1,909,557
+48,100
+3% +$3.63M
EW icon
25
Edwards Lifesciences
EW
$52.3B
$135M 1.35%
1,804,080

Similar funds

Railway Pension Investments's Q4 2022 Portfolio in Review

As of Q4 2022, Railway Pension Investments held 246 positions worth $9.95B, up 8% from $9.21B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Railway Pension Investments's Q4 2022 filing shows 12 new, 90 increased, 21 reduced and 23 closed positions. Its largest new stake was Comcast: 1,425,500 shares worth $49.8M. The largest sale was AbbVie, an estimated $92.9M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 33% a quarter earlier, followed by Technology and Consumer Staples.

  • Railway Pension Investments's largest Q4 2022 buy was Comcast: 1,425,500 shares worth $49.8M.
  • Railway Pension Investments added most to Pfizer in Q4 2022, an estimated $43.7M increase.
  • Railway Pension Investments's biggest Q4 2022 reduction was AbbVie, cutting an estimated $92.9M.
  • Railway Pension Investments fully exited IBM in Q4 2022, selling an estimated $47.2M.
  • Railway Pension Investments's ten largest holdings make up 22% of its $9.95B portfolio in Q4 2022.
  • Railway Pension Investments opened 12 new positions and closed 23 in Q4 2022.
  • Railway Pension Investments's portfolio value rose 8% quarter-over-quarter to $9.95B.

Based on Railway Pension Investments's 13F filing for Q4 2022, filed 27 Jan 2023.